Revance Therapeutics, Inc. $2,646,527 Glaukos Corp $3,948,467 Si-Bone, Inc. $0 Revance Therapeutics, Inc. $2,646,527 Glaukos Corp $3,948,467 Si-Bone, Inc. $0